InvestorBrandNetwork (IBN) Content Platform

RVL Pharmaceuticals (NASDAQ: RVLP) is a specialty pharmaceutical company focused on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. The company today announced financial results for the three months ended June 30, 2023, and provided an update on its business review. “During the past several months, we have focused on expense reduction to extend runway, optimize marketing mix, and support business development efforts. While this streamlining had a modest unfavorable impact on sales during the quarter, we have gained greater conviction that driving consumer awareness is the next lever that may unlock meaningful growth for UPNEEQ. Importantly, we have also compiled encouraging data around our large total addressable market, or TAM, and the exceptionally low level of consumer awareness for UPNEEQ,” said RVL’s Chief Executive Officer Brian Markison. “In addition, we have continued our strategic business review, and are in advanced discussions with certain companies that we could potentially partner with or acquire to support growth and integrate into our infrastructure with meaningful synergies.”

To view the full press release, visit https://ibn.fm/jtfYr

About RVL Pharmaceuticals plc

RVL Pharmaceuticals is a specialty pharmaceutical company focused on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. UPNEEQ is the first non-surgical treatment option approved by the FDA for acquired blepharoptosis. For more information about the company, visit www.RVLPharma.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

LQR House (NASDAQ: LQR), a company that intends to become the full-service digital marketing and brand-development face of the alcoholic beverage space, has closed on its initial public offering. The offering was comprised of 1 million shares of common stock, offered at $5 per share. According to the announcement, the underwriters exercised their overallotment option in full, resulting in an additional 150,000 shares of common stock at the time of the closing. Gross proceeds from the public offering, including overallotments, totaled approximately $5.75 million, before the deduction of any underwriting discounts or offering expenses. EF Hutton, a division of Benchmark Investments, acted as sole book-running manager for the offering.

To view the full press release, visit https://ibn.fm/kwGkJ

About LQR House Inc.

LQR House is a dynamic and forward-thinking e-commerce marketing company that intends to become the full-service digital marketing and brand-development face of the alcoholic beverage space. Currently, LQR House has a key partnership with Country Wine & Spirits Inc., granting the company full control over all marketing operations on CWSpirits.com, a large alcohol ecommerce platform. With a deep passion for the world of beverages, LQR House takes pride in curating marketing strategies aimed to elevate brands to new heights. Composed of a team of seasoned professionals, LQR House focuses on crafting marketing solutions tailored to each client’s unique needs. Through strategic partnerships, creative branding and digital prowess, LQR House intends to be at the forefront of the wine and spirits marketing landscape, making it the go-to choice for brands seeking to thrive in a competitive industry. For more information about the company, please visit www.LQRHouse.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

TRxADE Health (NASDAQ: MEDS), a pharmaceutical exchange platform provider, has filed for an extension to file its quarterly report. The company filed the extension on Form 10-Q for the second quarter pursuant to a Form 12b-25 filed with the U.S. Securities and Exchange Commission (“SEC”). According to the announcement, TRxADE is “not able to timely file its 10-Q by August 14, 2023, the original due date for such filing, without unreasonable effort or expense, because additional time is required to finalize its financial statements and related disclosures required to be included in the 10-Q in connection with the recent merger transaction it completed in July.” The company noted that it will release Q2 2023 financial results on Aug. 18, 2023, after the market closes.

To view the full press release, visit https://ibn.fm/QoVLg

About TRxADE Health Inc.

TRxADE is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The company operates the TRxADE drug-procurement marketplace serving more than 14,500 members nationwide, fostering price transparency and, under the Bonum Health brand, offering patient centric telehealth services. For more information about the company, please visit www.TRxADE.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Splash Beverage Group (NYSE American: SBEV), a portfolio company of leading beverage brands, today announced it has established a $10 million operating capital credit facility with a European and Singapore-based private funding group. According to the update, the company will use the credit facility along with additional funds raised for operating capital and will withdraw its existing $200 million S-3 Registration Statement. “We are very pleased to enter into this agreement and onboard capital from our existing investors. This $12.7 million in total ensures the company is well funded and will be used to fuel growth as we focus on reaching profitability,” said Splash’s CEO Robert Nistico. “The flexibility and availability of this capital allows us to retire our existing public shelf offering, which underscores our commitment to prudent capital allocation and responsible financial management. We remain committed to delivering value to our shareholders and are focused on executing our strategic plans to drive sustainable long-term growth.”

To view the full press release, visit https://ibn.fm/10Occ

About Splash Beverage Group Inc.

Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wines by the glass, SALT flavored tequilas, Pulpoloco sangrias, and TapouT performance hydration and recovery drinks. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution. For more information about the company, visit www.SplashBeverageGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced the signing of an agreement for two proof-of-concept (“POC”) projects with a leading global vehicle manufacturer. The POC projects aim to assess the accuracy of Foresight’s unique automatic calibration capabilities in enhancing 3D depth perception. In addition, the vehicle manufacturer will assess Foresight’s Mono2Stereo(TM) perception enhancement solution to be used with its existing mono cameras, which have different fields of view. “We believe that our collaboration with another leading global vehicle manufacturer validates the importance of Foresight’s technology in the automotive world and could lead to additional opportunities in the automotive sector,” said Haim Siboni, CEO of Foresight. “This vote of confidence from an important player in the automotive industry reinforces our commitment to develop advanced software-based vision solutions that will be widely implemented and could save lives by redefining road safety.”

To view the full press release, visit https://ibn.fm/HW0DN

About Foresight Autonomous Holdings Ltd.

Foresight is a technology company developing smart multi-spectral vision software solutions and cellular-based applications. Through the company’s wholly owned subsidiaries, Foresight Automotive Ltd., Foresight Changzhou Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions. Foresight’s vision solutions include modules of automatic calibration and dense three-dimensional (“3D”) point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobile’s cellular-based solution suite provides real-time pre-collision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.ForesightAuto.com.

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is reporting unaudited financial results for its first quarter, the period ended June 30, 2023, as well as recent business highlights. Financial numbers show cash total of C$9.3 million as of June 30, 2023, with the total increasing to C$18 million as of Aug. 14, 2023. Net loss for the quarter totaled C$14.5 million for the quarter with operating expenses reaching C$12.7 million for the quarter. Business highlights include the initiation of dosing in cohort 6, the final cohort of the company’s phase 2 study of CYB003 in Major Depressive Disorder (“MDD”), following the successful completion of cohort 5; a partnership with Worldwide Clinical Trials to support the future clinical development and regulatory strategy for CYB003 in MDD; the development of EMBARK(CT), a scalable psychedelic facilitation training program, designed to support larger pivotal studies; and continued advancement of the phase 1 CYB004-E study, with CYB004 dosing underway in part C, the final portion of the study. In addition, the company announces results of the Flow Kernel feasibility study, which Cybin sponsored; the results were published in the “Scientific Reports” journal.

The company also closed an $8.25 million marketed public offering to support the clinical development of CYBN’s CYB003 and CYB004 programs. “The steady clinical progress we have made over the past few months is truly encouraging, with dosing initiated in the final cohort of our phase 2 CYB003 MDD study and CYB004 dosing underway in part C of our phase 1 CYB004-E study,” said Cybin CEO Doug Drysdale in the press release. “We expect topline data for our CYB003 and CYB004 programs later this year, which we anticipate will provide insights into the therapeutic profile of our deuterated molecules as potentially differentiated treatments for mental health conditions. The recent marketed public offering further strengthens our position to deliver on these value-driving milestones. I am proud of the Cybin team’s thoughtful approach and strategic decisions that have enabled us to accelerate our clinical-stage programs. We look to build on this momentum as we advance to future pivotal studies, with work already underway in developing a scalable version of our EMBARK psychedelic facilitation program and through our partnership with Worldwide Clinical Trials, a global contract research organization.”

To view the full press release, visit https://ibn.fm/88k4b

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder; the company also has a research pipeline of investigational psychedelic-based compounds. For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Lottery.com (NASDAQ: LTRY), a leading provider of lottery results data servicing global publishers, search engines and voice assistants, has appointed Christopher Anderson Gooding to its board of directors, a move the company is calling “another important step in a new era of compliance with NASDAQ.” Gooding brings an impressive resume to his new responsibility. He has served for decades at respected law firms, primarily those in  the heart of London’s financial district. His roles have included partner, consultant, director, and legal strategist. Gooding has rich experience, particularly in the corporate landscape, where he has been a founding director of a substantial N.Y.-based hedge fund valued at more than $500 million, served on the boards of companies in aviation and insurance, and led initiatives in the green-energy and aviation sectors.

According to the announcement, Lottery.com is focusing on resuming operations in three major segments of its business model — B2C ticket sales, international expansion and technology licensing — before the end of the year. “We extend a very warm welcome to Christopher,” said Lottery.com board chairman and interim CEO Matthew McGahan in the press release. “The appointment of an individual of his stature enriches our board substantially. His legal acumen, coupled with a deep understanding of corporate governance, greatly augments our combined senior leadership experience. Bolstered by these strategic appointments and solid UCIL financing, we now have a much more robust operational and financial foundation to execute on our business plan. As we lean in to the second half of our fiscal year, our strategy’s central interest is to restore the company’s revenue-driving operations. Our business is easily scalable, contains inherent potential and we look forward to updating the market on these and other positive developments in due course.”

To view the full press release, visit https://ibn.fm/jS28A

About Lottery.com Inc.

Lottery.com, Inc. is a leading technology company that is transforming how, where and when lotteries are played. Its engaging mobile and online platforms enable players and commercial partners located throughout the United States and other countries to remotely purchase safe and legally sanctioned lottery games. Lottery participants look to the Company’s website, Lottery.com, for compelling, real-time results on more than 800 lottery games from more than 40 countries. Lottery.com’s mission remains the same: an uncompromising passion to innovate, grow a new demographic of enthusiasts, deliver responsible and trusted solutions, and promote community and philanthropic initiatives. To learn more about the company, visit www.Lottery.com.

NOTE TO INVESTORS: The latest news and updates relating to Lottery are available in the company’s newsroom at https://ibn.fm/Lottery

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Golden Matrix (NASDAQ: GMGI), a developer, licensor and global operator of online gaming and eCommerce platforms, systems and gaming content, announced that the company is reporting record third-quarter revenues for the period ending July 31, 2023. According to the announcement, revenues for the period exceeded $11 million, with significant contributions coming from RKings Tournament Competitions, the company’s B2C segment operating in the United Kingdom. The company noted that operational improvements at RKings accounted for the revenue growth, including the introduction and popularity of an expanded tournament platform offering multiple prizes of various types and prices. The company noted that another factor in the uptick in revenue is the continued growth of GMGAssets, a complementary business that offers those who win an expensive car or other high-ticket item in RKings tournaments the option to choose a predetermined cash prize instead.

According to the report, RKings revenue from tournament competitions and GMGAssets in Q3 totaled $5.8 million and $1.7 million, respectively. The company also noted that its fully regulated online casino and sportsbook MEXPLAY continues to show consistent progress since its launch earlier this year. “July marked our best monthly financial results at RKings since it was acquired almost two years ago,” said Golden Matrix CEO Brian Goodman in the press release. “It contributed $7.5 million toward total revenues in the quarter, which is $1 million more than contributions of about $6.5 million generated in both Q1 and Q2. . . . In addition to generating record revenues exceeding $11 million for the first time, we made excellent progress during the quarter in securing the financing required to complete the acquisition of the MeridianBet Group; and we anticipate sending out the proxy statement later this month for shareholder approval. Obviously, we are extremely excited to complete this transaction, as it will transform GMGI into a dynamic and highly profitable global gaming company.”

To view the full press release, visit https://ibn.fm/f4Jie

About Golden Matrix Group Inc.

Golden Matrix Group, based in Las Vegas, Nevada, is an established B2B and B2C gaming technology company operating across multiple international markets. The B2B division of Golden Matrix develops and licenses proprietary gaming platforms for its extensive list of clients. RKings, GMGI’s B2C division, operates a high-volume ecommerce site enabling end users to enter paid-for competitions on its proprietary platform in authorized markets. The company also owns and operates MEXPLAY, a regulated online casino in Mexico. The company’s sophisticated software automatically declines any gaming or redemption requests from within the United States, in strict compliance with current U.S. law. For more information about the company, visit www.GoldenMatrix.com.

NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and supporting personalized digital coaching programs, has secured an additional $6.5 million in nondilutive funding. The company announced the funding was secured through a clean debt facility with no warrants or convertible elements from an existing lender. In addition, the company noted that it recently participated in the American Diabetes Association meeting, the world’s largest gathering of diabetes professionals. The company demonstrated product at the event, receiving “very encouraging feedback” from attendees including corporate officials, diabetes service providers and clinicians. “The company is also currently undertaking studies with the National Health Service (‘NHS’) in the UK with its metabolic health program designed for the consumer market targeting obesity and prediabetes whilst refining its commercial offering in this space,” the announcement stated. “Nemaura also continues to support its UK licensee with its application for reimbursement of sugarBEAT(R) in the UK.”

To view the full press release, visit https://ibn.fm/mfWpo

About Nemaura Medical Inc.

Nemaura Medical is a medical technology company developing and commercializing noninvasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R) and proBEAT(TM). sugarBEAT, a CE mark-approved class IIb medical device, is a noninvasive and flexible continuous glucose monitor (“CGM”) that provides actionable insights derived from real-time glucose measurements and daily glucose trend data, which may help people with diabetes and prediabetes to better manage, reverse and prevent the onset of diabetes. Nemaura has submitted a premarket approval application (“PMA”) for sugarBEAT to the U.S. Food and Drug Administration (“FDA”). proBEAT combines noninvasive glucose data processed using artificial intelligence (“AI”) under a digital healthcare subscription service as part of NMRD’s BEAT diabetes program. Nemaura sits at the intersection of the global type 2 diabetes market, which is expected to reach nearly $59 billion by 2025; the $50-plus billion prediabetic market; and the wearable health-tech sector for weight loss and wellness applications, which is estimated to reach $60 billion by 2023. For more information about the company, visit www.NemauraMedical.com.

NOTE TO INVESTORS: The latest news and updates relating to NMRD are available in the company’s newsroom at https://ibn.fm/NMRD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Astra Energy (OTCQB: ASRE), a renewable and waste-to-energy project developer and technology acquisition company, announced that it has paid off the only convertible note on the company’s balance sheet. According to the announcement, Ron Loudoun, the company’s new chair and CEO, prepaid the note to avoid any potential dilution to the company’s stock and to protect shareholder interest. Loudoun brings an impressive resume to his new position, with  experience in business development and operational leadership as well as a proven track record of achieving common goals that advance aligned strategic priorities for the companies he is serving. “Astra is at a very exciting operational inflection point,” said Astra Energy CEO and chair Ron Loudoun in the press release. “Years of concerted effort and business development have brought the company to a point where both the Holcomb and Regreen technologies can be presented to a backlog of potential customers. With manufacturing in place, the timing for this company to advance could not be better. We are looking forward to a very rewarding time for all stakeholders.”

To view the full press release, visit https://ibn.fm/g0iU9

About Astra Energy Inc.

Astra Energy is an integrated solutions provider investing in and developing clean and renewable energy projects in markets where demand is high, supply is limited and there is an opportunity to address other imminent market needs. Astra’s corporate strategy is rooted in securing technologies and assets; identifying viable market opportunities; and bringing together resources, expertise, technology and defined action plans to execute first-in-class projects that benefit communities, local economies, the planet and the company’s investors. The company’s goal is to create a more secure and sustainable power sector that supports its purpose, mission and values to transform the economic, environmental and social landscape for generations to come. For further information about the company, visit www.AstraEnergyInc.com

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Breezer Ventures (OTC: BRZV) and its wholly owned subsidiary, Magnum Finest Spirits Inc., are key players in the $1.6 trillion global alcohol drinks industry, and the companies are discussing Magnum’s potential for growth and development in the space. According to the announcement, Breezer and Magnum’s goal is to capture a significant piece of the market using centuries-old distilling techniques” along with effective marketing to create a long-term relationship between consumers and the Magnum 1770 brand. The company noted that liquor companies that have focused on this objective have often been ”rewarded handsomely by buyouts from global alcohol distribution conglomerates like Diageo.” In addition, the company noted celebrity endorsements and deals that similar companies have announced, which illustrate that the value in a successful liquor company can be measured internationally.

The discussion noted, however, that many of these companies are private corporations, which means there is no opportunity for the general population to invest or profit from this potential. “In spirits, the expected growth rate through 2026 is a strong 5.9%,” the company reported in the press release. “In the alcohol drinks industry, population growth is the main driver of the market. Global population growth is expected to reach 10 billion by 2050. . . . The industry has been stuck on glass and plastic for decades, neither are effectively recycled, contrary to popular opinion. Magnum’s goal using BiB packaging is to pioneer change in the consumer’s perception of boxed alcohol. . . . The box is a statement. It delivers that high-quality product in ecofriendly packaging, with cardboard being easily recyclable, biodegradable and even compostable. It is cheaper to produce and has a lower carbon footprint than glass. It is also lighter, safer and more cost effective to everyone along the way, easier and cheaper to transport or ship, from the distiller to the distributor/wholesaler, to the retailer and consumer. Breezer and Magnum management consider themselves very fortunate to have world-class spirits made by their partners with 300 years’ experience.”

To view the full press release, visit https://ibn.fm/rD7WL

About Breezer Ventures Inc./Magnum Finest Spirits Inc.

Magnum is a distilled spirits and marketing company offering products with a centuries-long history of outstanding quality. What separates Magnum from industry peers is its functionally innovative and environmentally conscious Bag in a Box (“BiB”) packaging and distinctive billboard-style labeling. Never to be associated with discount or bulk, top-shelf Magnum 1770-branded products include an exceptional Bourbon, premium Vodka and an esteemed Gin, as well as trending Flavored Spirits. The company plans to expand on its relationships with the big box wine and liquor stores, warehouse liquor emporiums, traditional liquor stores, VIP and trending restaurants, bars and nightclubs. For more information about this company, please visit www.MagnumFinestSpirits.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, has signed a paid proof of concept (“POC”) project with the Chinese subsidiary of one of the world’s leading manufacturers of industrial equipment, heavy machinery, construction and mining equipment. According to the announcement, the Fortune 500 company is evaluating the ability of Foresight’s QuadSight(R) technology to provide autonomous capabilities to the company’s mining and construction trucks; a successful outcome may mean that FRSX’s proprietary tech could be integrated into future vehicles. The company noted that it was chosen over other three-dimensional perception vision solutions because of its accurate and high-resolution point cloud and all-object detection capabilities in diverse circumstances, including harsh weather, environment and lighting conditions. “We are excited to extend our innovative stereo vision solutions to the construction and mining industry,” said Foresight CEO Haim Siboni in the press release. “By collaborating with one of the world’s largest industrial equipment and heavy machinery manufacturers, we aim to enhance the safety, accuracy of object detection, and environmental awareness in their operations. This POC project reflects our dedication to delivering advanced automotive vision technologies across diverse sectors.”

To view the full press release, visit https://ibn.fm/DTdb3

About Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings is a technology company developing smart multispectral vision software solutions and cellular-based applications. Through the company’s wholly owned subsidiaries — Foresight Automotive Ltd., Foresight Changzhou Automotive Ltd. and Eye-Net Mobile Ltd. — Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions. Foresight’s vision solutions include modules of automatic calibration and dense three-dimensional (“3D”) point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobile’s cellular-based solution suite provides real-time, precollision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information, visit the company’s website at www.ForesightAuto.com.

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Fintech Ecosystem Development Corp. (NASDAQ: FEXD), a special purpose acquisition company (“SPAC”), is exploring the use of artificial intelligence (“AI”) to power financial solutions. “As a company that understands the financial sector, FEXD knows the potential that artificial intelligence (‘AI’) has and the value it brings in transforming an industry that has, for a long time, arguably lacked innovation,” a recent article reads. “With a growing range of applications, from simple chatbots to credit risk management tools, AI is finding its way to the core of financial solutions, and all stakeholders welcome it. So far, JPMorgan Chase, critical among other players in its space, has reported leveraging AI for fraud detection for its account holders. As a showcase of what AI is capable of, the bank has been able to implement a proprietary algorithm that detects fraud patterns, earning it high scores in both security and reliability. This, along with other additional benefits, such as speeding up services, allowing financial institutions to make more informed risks, and creating avenues for better customer relationship management, point to the potential of AI in the financial space. By focusing on such, FEXD is pushing the AI conversation forward while exploring ways to develop this technology further to address unmet mobile money needs in developing and industrialized countries and markets.”

To view the full article, visit https://ibn.fm/eKbRm

About Fintech Ecosystem Development Corp.

Fintech Ecosystem Development is a special purpose acquisition company formed for the purpose of effecting one or more business combinations with an intent to focus on the financial technology sector. The company is sponsored by Revofast LLC and the management team led by CEO, president and founder Dr. Saiful Khandaker and a group of experienced fintech business and technology innovators. For more information about the company, please visit www.FintechEcosys.com.

NOTE TO INVESTORS: The latest news and updates relating to FEXD are available in the company’s newsroom at https://ibn.fm/FEXD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing-related sleep issues arising from certain dentofacial abnormalities, anticipates releasing its second quarter 2023 financial results on Aug. 14, 2023, after the market closes. In addition, the company announced that it will host a conference call and webinar to discuss the report and provide an overview of the company’s milestones and developments; the call will at 5 p.m. ET, also on Aug. 14. Those interested in listening to the call can dial toll-free at 888-886-7786; international callers may dial 416-764-8658. A replay of the event will be available after the call and can be accessed by dialing 844-512-2921 (412-317-6671 for international callers). All calls will require the following passcode: 22348893.

To view the live webcast, visit https://ibn.fm/2cPET

To view the full press release, visit https://ibn.fm/pbrHf

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) and snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to moderate OSA. It has proven effective (within the scope of FDA-cleared uses) in the treatment of more than 40,000 patients worldwide by more than 1,800 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.VivosLife.com.  

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Exro Technologies (TSX: EXRO) (OTCQB: EXROF), a leading clean-technology company that has developed new-generation power control electronics that expand the capabilities of electric motors and batteries, has released its financial results for the three months and six months ending June 30, 2023. Highlights of the report included revenue of $2,443,292 for the three-month period and $2,768,061 for the six-month period; the signing of a definitive commercialization agreement with Linamar Corporation, a global tier-1 automotive supplier; the closing of a common share bought deal financing for aggregate gross proceeds of of $34,931,250; and the election of three new directors — Aleksandra Miziolek, Anita Ganti and Frank Simpkins ­— along with the appointment of board chair Rod Copes. “The second quarter of 2023 demonstrated continued progress towards commercialization of our next generation technologies for electric vehicles and stationary energy storage,” said Exro Technologies CEO Sue Ozdemir in the press release. “We finished the quarter in a strong financial position, significantly expanded the expertise of our board of directors, and are in final preparations to start our production before the end of Q3. We have customers proceeding towards additional purchase orders and are digging in with our new leading global automaker partner on our power train innovation project — evidence that we are capitalizing on the efforts we have put in over the last three years.”

To view the full press release, visit https://ibn.fm/uNArZ

About Exro Technologies Inc.

Exro is a clean-tech company that has developed a new class of control technology for electric powertrains. Exro’s advanced motor-control technology, its Coil Driver, expands the capabilities of electric motors and powertrains. The Coil Driver enables two separate torque profiles within a given motor. The first is calibrated for low speed and high torque, while the second provides expanded operation at high speed. The ability to change configuration allows efficiency optimization for each operating mode, resulting in overall reductions in energy consumption. The controller automatically and seamlessly selects the appropriate configuration in real-time so that torque demand and efficiency are optimized. The limitations of traditional electric machines and power technology are becoming more evident. In many increasingly prominent applications, traditional methods cannot meet the required performance. This means either oversizing the equipment, adding additional motors or implementing heavy mechanical-geared solutions. Exro offers a new solution for system optimization through implementation of the technology, which can yield the following results: increased drive cycle efficiency, reduced system volume, reduced weight, and expanded torque and speed capabilities. Exro allows the application to achieve more with less energy consumed. For more information about the company, please visit www.Exro.com.

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Predictive Oncology (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (“CLIA”) laboratory and Good Manufacturing Practices (“GMP”) facility to accelerate oncology drug discovery and enable drug development, is reporting on its Q2 2023 performance. The company reported financial and operating results for the three and six months ended June 30, 2023. Highlights of the report include the initiation of collaborations with PEDAL-Cancer Research Horizons for the analysis of drug compounds and with Cvergenx to identify novel molecules and compounds and the repurposing of radioprotective or radiosensitizing drugs; a presentation at the Bio International Convention focused on the importance of addressing patient heterogeneity in drug discovery and the advantages of leveraging active machine learning; and meetings with more than 30 biopharmaceutical development customer prospects along with further expansion of the company’ sales pipeline.

In addition, the company moved its corporate headquarters to Eagan, Minnesota, and established a new business advisory board with two members thus far and added a member to its board of directors. “We are very pleased with the steady progress that we have made since our last quarterly update, both advancing current PEDAL relationships with CRH, Cvergenx and others, while in parallel building our pipeline as more drug developers — both biopharmaceutical companies as well as research institutions — see the value that only Predictive Oncology can bring to the early drug-discovery process,” said Predictive Oncology CEO and chair Raymond F. Vennare in the press release. “With our unique set of assets and capabilities that clearly set us apart from other AI-focused drug discovery companies, including our extensive biobank of more than 150,000 tumor samples, combined with our CLIA lab, we can validate our predictions in wet-lab experiments in a setting that introduces patient heterogeneity into the earliest phases of drug discovery. We are the only company capable of doing this, and the results of these experiments can significantly increase the chances of later-stage clinical success by our customers.”

To view the full press release, visit https://ibn.fm/nAnha

About Predictive Oncology Inc.

Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence (“AI”) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy if a tumor sample will respond to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. With the company’s vast biobank of more than 150,000 assay-capable heterogenous human tumor samples, Predictive Oncology offers its academic and industry partners one of the industry’s broadest AI-based, drug-discovery solutions, further complemented by its wholly owned CLIA lab and GMP facilities. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vistagen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, is reporting its financial results for the first quarter of 2024, the period ending June 30, 2023; the company also released a corporate update. Highlights of the report include positive top-line results from the company’s phase 3 PALISADE-2 trial of rapid-onset fasedienol (“PH94B”) nasal spray in social anxiety disorder (“SAD”); the staging of itruvone (“PH10”) nasal spray for phase 2B clinical development as a standalone, nonsystemic treatment for major depressive disorder (“MDD”); and optimism for the treatment of moderate to severe vasomotor symptoms, or hot flashes, in women experiencing menopause based on the positive exploratory phase 2A trial of VTGN’s PH80 (“PH80”) nasal spray. In addition, company Q1 2024 financial results show that R&D expenses decreased from $15.3 million to $4.2 million for the quarter; general and administrative expense decreased to $3 million from $4.8 million for the quarter ended June 20, 2022; net loss was approximately $6.9 million compared to $19.8 million for Q1 2022; and cash and cash equivalents for the company total approximately $9.6 million.

“The positive outcome of our PALISADE-2 study demonstrated that fasedienol significantly reduced the mean Subjective Units of Distress Scale score, reducing anxiety during a stressful public-speaking challenge,” said Vistagen CEO Shawn Singh in the press release. “The study outcome is a pivotal achievement for fasedienol and our diverse pherine platform. These results mark the first positive U.S. phase 3 study of an investigational therapy for social anxiety disorder in over 15 years. We believe these results reinforce the promise of our pherine pipeline to address growing unmet treatment needs. We now move forward confidently advancing the phase 3 program for fasedienol in SAD with planning for initiation of additional phase 3 studies in 2024. Our strong understanding of each pherine product candidate’s scientific and therapeutic potential gives us confidence in our ability to continue to innovate for patients and deliver long-term value for shareholders. With a collective body of positive safety and efficacy studies supporting our clinical-stage pipeline, we believe there are many strategic paths to accelerate our progress in achieving key clinical and regulatory milestones for each program over the next 12 months.”

To view the full press release, visit https://ibn.fm/lfa6D

About Vistagen Therapeutics Inc.

Vistagen Therapeutics is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster acting and with fewer side effects and safety concerns than treatments that are currently available for treatment of anxiety, depression and multiple CNS disorders. Vistagen’s pipeline includes six clinical-stage product candidates, including fasedienol (“PH94B”), itruvone (“PH10”), PH15, PH80 and PH284, each an investigational agent belonging to a new class of drugs known as pherines, as well as AV-101, which is an oral prodrug antagonist of the N-methyl-D-aspartate receptor (“NMDAR”). Pherines are neuroactive nasal sprays designed with an innovative proposed mechanism of action that activates chemosensory neurons in the nasal cavity and can beneficially impact key neural circuits in the brain without systemic uptake or direct activity on CNS neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety, depression and several other CNS disorders. For more information about the company, please visit www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, will be presenting at this month’s Sidoti & Co. Micro Cap Virtual Conference. The two-day event is scheduled for Aug. 16–17, 2023. According to the announcement, PCSA’s president of research and development, David Young, will attend the conference and will present on Processa Pharmaceuticals at 11:30 a.m. ET on Aug. 17. In addition to Young’s presentation, company officials including CEO George NG will be available for one-on-one meetings with potential investors and other interested parties.

To view the presentation, visit https://ibn.fm/GaMaa

To view the full press release, visit https://ibn.fm/PnUzI

About Processa Pharmaceuticals Inc.

Processa is a clinical-stage pharmaceutical company focused on developing the next-generation chemotherapy (“NGC”) drugs to improve the safety and efficacy of cancer treatment. By combining Processa’s novel oncology pipeline with proven cancer-killing active molecules and the Processa Regulatory Science Approach as well as experience in defining Optimal Dosage Regimens for FDA approvals, Processa not only will be providing better therapy options to cancer patients but also will increase the probability of FDA approval for its next-generation chemotherapy drugs following an efficient path to approval. Processa’s NGC drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells. The company’s approach to drug development is based on more than 30 years of drug-development expertise to efficiently design and conduct clinical trials that demonstrate a positive benefit/risk relationship. Using its proven Regulatory Science Approach, the company has experience defining the Optimal Dosage Regimen using the principles of the FDA’s Project Optimus Oncology initiative. The advantages of Processa’s NGC drugs are expected to include fewer patients experiencing side effects that lead to dose discontinuation; more significant cancer response; and a greater number of patients who will benefit from each NGC drug. Currently in the company pipeline are three NGC drugs: Next Generation Capecitabine (PCS6422 and capecitabine to treat metastatic colorectal, gastrointestinal, breast, pancreatic and other cancers), Next Generation Gemcitabine (PCS3117 to treat pancreatic, lung, ovarian, breast and other cancers), and Next Generation Irinotecan (PCS11T to treat lung, colorectal, gastrointestinal, pancreatic and other cancers). For more information, visit the company’s website at www.ProcessaPharma.com. 

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Flora Growth (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000-plus points of distribution around the world, is reporting on its three-month and six-month performance, for the period ending June 30, 2023. Highlights for the quarter include a 140% increase in year-over-year revenue, which came in at $21.5 million; a 19% increase in gross profits, which totaled $4 million; and a net loss of $44.6 million, which includes the impact of impairment expenses of $34.9 million, losses on discontinued operations of $7.6 million, depreciation and amortization of $0.9 million and share-based compensation of $0.3 million. Year-to date highlights include an overall 210% increase in year-over-year revenue, which was $40.8 million; gross profit of $9.3 million, which represents a 68% year-over-year increase; and net loss of $48.5 million, which the report noted includes the impact of impairment expenses of $34.9 million, losses on discontinued operations of $8.3 million, depreciation and amortization of $1.7 million and share-based compensation of $1.0 million.

The company has scheduled a conference call hosted by senior management to discuss the report. The call is slated for Aug. 15, 2023, at 9 a.m. EST. Those interested can access the call by dialing toll-free 1-800-319-4610 (North America) or 1-604-638-5340 (international toll). “The second quarter marked a transitional phase for Flora,” said Flora Growth CEO Clifford Starke in the press release. “Our dedicated efforts were focused on cost reductions and resource optimization, the effects of which are expected to be felt in quarters to come. Throughout this rebuilding phase, we will continue to prioritize Flora as a leading consumer brand globally.”

To view the full press release, visit https://ibn.fm/x3w0E

About Flora Growth Corp.

Flora Growth is a consumer-packaged goods leader serving all 50 states with 20,000-plus points of distribution around the world. For more information about the company, please visit www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is reporting on its second-quarter and half-year results for the period ended June 30, 2023. Highlights of the report include record daily mill throughput of 1,250 tonnes per day at Fox Complex, generating $6 million in cash gross profit during the quarter, with sustained higher throughput and improved grade expected to result in stronger production and margins in the coming months; a production increase of 54% at San José, with cash costs per ounce declining 24% compared to first quarter as the revised mine plan continues to be executed; higher mining rates and gold grades at Gold Bar, which is also reporting faster recovery and lower strip ratio from the Pick deposit, setting the stage for improved production and margins in the second half of 2023 and beyond; and progress being made toward a formal construction decision at the Fenix project, where a sonic drilling program has been initiated along with progress made on permitting applications and hiring a project manager. In addition, the company is reporting early retirement of $25 million, or 39%, of its outstanding debt during the second quarter with a safety track record of no lost-time incidents at its wholly owned operating mines.

“The year started with operational challenges at both Gold Bar and San José,” said McEwen Mining chair and chief owner Rob McEwen in the press release. “San José appears to have turned the corner, and we are confident that the plan in place for Gold Bar will do the same. Fox Complex has delivered another solid quarter, and we expect even better results in the second half of the year. We thank our operating teams for their hard work. The story at Los Azules keeps getting better and better. With a strong financing, an updated Preliminary Economic Assessment (‘PEA’) showing robust economics, unparalleled partners in Rio Tinto (through Nuton) and Stellantis, and potentially game-changing copper leaching technology, we could see Los Azules provide a model for how the mine of the future should look.”

To view the full press release, visit https://ibn.fm/TxYTx

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, the company owns approximately 52% of McEwen Copper, which owns the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. McEwen Mining chair and chief owner Rob McEwen has a personal investment in the company of $220 million; his annual salary is $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Breezer (OTC: BRZV), a trailblazer in the luxury lifestyle branding market, is aiming to revolutionize the liquor industry. The company today announced the launch of its exclusive corporate website at www.MagnumFinestSpirits.com, which was meticulously designed to showcase its heritage, products, community and expertise. It also upholds the most stringent disclosure standards, providing investors with easy access to the company’s filings with the Securities and Exchange Commission (“SEC”), up-to-the-minute stock quote and price data, and its vibrant social media channels. “Breezer Ventures isn’t just a corporate entity; it’s a vision,” said Breezer’s CEO Freddy Figueroa. “A vision fueled by the Tiller family’s unparalleled distilling heritage, documented back to 1731, and fully deployed for the 21st century. Their age-old family recipes, combined with Magnum 1770’s modern approach, are the cornerstones of our brand. We’re on a mission to elevate Magnum 1770, pushing boundaries and transcending the traditional realm of boxed lifestyle products.”

To view the full press release, visit https://ibn.fm/xiBXg

About Breezer Ventures Inc. / Magnum Finest Spirits Inc.

Magnum is a distilled spirits and marketing company offering products with a centuries-long history of outstanding quality. What separates Magnum from industry peers is its functionally innovative and environmentally conscious bag-in-a-box (“BiB”) packaging, and distinctive billboard style labeling. Never to be associated with discount or bulk, top shelf Magnum 1770 branded products include an exceptional bourbon, premium vodka, an esteemed gin, as well as trending flavored spirits. The company plans to expand on its relationships with the big box wine and liquor stores, warehouse liquor emporiums, traditional liquor stores, VIP and trending restaurants, bars, and nightclubs. Magnum has offices in Las Vegas, Nevada, and Murrieta, California. For more information, visit www.MagnumFinestSpirits.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

GlobalX (NEO: JET, JET.B) (OTCQB: JETMF) has closed the placement of $35 million of senior secured notes due in 2029 with funds managed by Axar Capital Management LP and its affiliates, a value-oriented alternative investment firm managing over $2.3 billion in assets. The proceeds from the notes will refinance all of the company’s existing indebtedness and provide GlobalX the capital required to continue to execute its growth plan and expand its passenger and freighter aircraft fleet from 11 aircraft to at least 16 by year-end 2023. ROTH MKM acted as joint placement agent for the placement.

To view the full press release, visit https://ibn.fm/x9R8y

About Global Crossing Airlines Group Inc.

GlobalX is a U.S. 121 domestic flag and supplemental airline flying the Airbus A320 family aircraft. GlobalX flies as a passenger ACMI and charter airline serving the U.S., Caribbean, European and Latin American markets. GlobalX is also now operating ACMI cargo service flying the A321 freighter. For more information, visit www.GlobalXAir.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, announced the pricing of its current public offering. The offering consists of up to 4,615,385 shares of the company’s common stock and warrants for purchase at $0.65 per share. According to the announcement, the warrants, which will expire on Oct. 10, 2028, will be immediately exercisable at an exercise price of $0.65 per share. The company anticipates gross proceeds from the offering to be approximately $3 million, before deductions such as placement agent fees and other offering expenses. The offering should close on or about Aug. 14, 2023, and will be subject to customary closing conditions. 180 Life Sciences expects to use the funds from the offering for R&D expenses as well as general corporate purposes, including the preparation of a marketing authorization application for Dupuytren’s Contracture and legal expenses. A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering.

To view the full press release, visit https://ibn.fm/7Y8E2

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research and, where appropriate, combination therapy. The company’s current primary focus is a novel program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). For more information about the company, visit www.180LifeSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at https://ibn.fm/ATNF 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it has retained the services of Clarivate(TM), a leading global provider of information services including IP lifecycle management solutions. Under the agreement, Clarivate will manage, maintain and track Silo Pharma’s intellectual property assets and technology rights, and serve as an advisor for strategic IP and patent expansion in support of pipeline development. “Our new agreement with Clarivate gives us the opportunity to step up our intellectual property and patent expansion efforts and reinforce protection for our novel assets under development,” said Eric Weisblum, chief executive officer of Silo Pharma. “Clarivate’s IP intelligence solutions will provide insights and clarity to inform our pursuit of future opportunities.”

To view the full press release, visit https://ibn.fm/qS9H4

About Silo Pharma Inc.

Silo Pharma is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer’s disease and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research, which it believes will be transformative to the well-being of patients and the health care industry. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products, today announced that its OEM manufacturer, Global Safe Tracks, has received its first production run and started shipping units into Germany and the U.K. An additional 1,000 devices are going into production based on the initial positive feedback and forecast. Global Safe Tracks is licensed to manufacture a modified version of the GPS SmartSole that includes 2G technology as a fall back to 4G technology for countries where 4G coverage has not been fully implemented. “Since announcing our manufacturing partnership last week , we have seen immediate benefits across the supply chain,” said MetAlert CEO Patrick Bertagna. “By having an extra factory and point of distribution in Germany, we were able to fill orders for the U.K. within days, saving time and freight costs, back orders from Germany were quickly filled, saving time and costs, which then prompted an additional 1,000 units to go into production, as customer were seeing the improvements in our ability to ship orders. During the same time frame, we received a shipment from our U.S. factory and orders were immediately shipped out to our U.S. customers.”

To view the full press release, visit https://ibn.fm/ACW90

About MetAlert Inc.

MetAlert and its subsidiaries are engaged in designing, developing, manufacturing, distributing, selling and licensing products, services and intellectual property in the GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. With over 20 years of experience and an extensive patent portfolio, MetAlert is a leading solution provider for consumers/patients afflicted with Alzheimer’s, dementia and autism. This market represents approximately 2.9% of the world’s population. The company offers global end-to-end hardware, software and connectivity solutions, in addition to developing two-way tracking technologies, which seamlessly integrate with consumer products, enterprise and government agency applications. Utilizing the latest in miniaturized, low power consumption GPS, cellular, RF, NFC, and BLE technologies, enabling caregivers to track and monitor patients in real time. MetAlert is known for its game-changing and award-winning patented GPS SmartSole(R) — think Dr. Scholl’s meets LoJack, the world’s first invisible wearable technology tracking device created for those at risk of wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. MetAlert’s subscription-based business model is built around technology innovation with intellectual property protection. The company has international distributors servicing customers across the globe with subscribers in over 40 countries and is a U.S. military government contractor. Other customers include public health authorities, municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes and consumers. For more information, visit the company’s website at www.MetAlert.com.

NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Siyata Mobile (NASDAQ: SYTA, SYTAW) (TSX.V: SIM), a global vendor of Push-to-Talk (“PTT”) over Cellular (“PoC”) and cellular signal booster solutions, announced the newest member of its board of directors. The company has appointed Gary Herman to the board; he will replace Michael Kron. According to the announcement, Herman has garnered several decades of experience as a public company investor, fund manager and investment banker. He has also served as a corporate officer, capital raiser and restructuring specialist, and has also been on boards for both public and private companies; he is currently a board member for Jupiter Wellness Inc. (NASDAQ: JUPW), XS Financial Inc. (CSE: XS) and SusGlobal Energy Corp. (OTCQB: SNRG). “Gary’s deep experience as a public company board member and investor will add a tremendous resource to our board of directors,” said Siyata Mobile board chair Peter Goldstein in the press release. “His knowledge and expertise, along with his broad experience spanning many different industries and geographies will add valuable leadership and investment acumen as we continue to build a Board that is shareholder return focused.”

To view the full press release, visit https://ibn.fm/VPUH1

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next-generation, Push-to-Talk over cellular devices, cellular booster systems and video-monitoring systems. Its portfolio of in-vehicle and rugged devices enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. The company’s portfolio of enterprise-grade and consumer cellular-booster systems enables first responders and enterprise workers to amplify cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for the maximum cellular signal strength possible. For its video monitoring system, Siyata integrates software licensed with off-the-shelf hardware providing customers with an integrated advanced camera system for management and visual monitoring of their fleet vehicles. For more information about the company, visit www.SiyataMobile.com or www.UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at http://ibn.fm/SYTA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Motobyo, a burgeoning automotive e-commerce powerhouse, has announced a live webinar slated for Aug. 22, 2023, at 2 p.m. ET. The webinar, which is for accredited investors, will include an in-depth discussion about the key role auto dealers play in the Motobyo ecosystem and how auto dealers support the business model. Hosting the live event will be Motobyo CEO and founder George Lekas and premier dealer partner and High Street Auto Connection president Anthony Gasparro. According to the announcement, Motobyo is seeking accredited investors to join the company in changing the way that more than 40 million used-car transactions are completed each year. With its powerful asset-free business model that eliminates industry inefficiencies and connects supply directly to demand, Motobyo offers a unique opportunity to capitalize on the shifting dynamics of the $1.6 trillion used-car market. The company has recently raised a $2.5 million seed round of capital to support its launch and created 3,000 accounts in 48 states, with monthly account sign-ups increasing by 300% since Jan. 1, 2023.

To view the webinar, visit https://ibn.fm/wLTEe

To view the full press release, visit https://ibn.fm/KWE9r

About Motobyo

Motobyo, a private-party online automotive marketplace, utilizes a patent-pending pricing technology that allows its one-of-a-kind platform to deliver the most comprehensive solutions for private consumers looking to buy or sell a vehicle. Motobyo has raised the bar with “Instant Cash Offers” and guaranteed sales, as well as other products and services typically only provided by dealerships. For more information about the company, please visit www.Motobyo.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced financial results for the second quarter 2023 and provided a corporate and commercial update. “During the second quarter, we saw a continuation of the many positive trends that have contributed to our improved financial profile, including growing revenue contribution from highly scalable business-to-business (‘B2B’) customers, expanding gross margins, and reduced operating expenses as compared to the same period last year,” said Erez Raphael, chief executive officer of Dario. “Of note, we increased our gross profit margin to 33.7% in the second quarter of 2023 compared to 18.4% in the second quarter of 2022. Our proforma gross margins increased to 51.5% in the second quarter of 2023, up significantly from 36.1% in the second quarter of 2022, while reducing our operating expense run rate by 13% over that period.”

To view the full press release, visit https://ibn.fm/ZuPf8

About DarioHealth Corp.

DarioHealth is a leading digital health company, revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Its platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. Dario’s user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to health care. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payers, self-insured employers, providers of care and directly to consumers. To learn more about Dario and its digital health solutions, or for more information, visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is reporting on its second-quarter and half-year results for the period ended June 30, 2023. Highlights of the report include record daily mill throughput of 1,250 tonnes per day at Fox Complex, generating $6 million in cash gross profit during the quarter, with sustained higher throughput and improved grade expected to result in stronger production and margins in the coming months; a production increase of 54% at San José, with cash costs per ounce declining 24% compared to first quarter as the revised mine plan continues to be executed; higher mining rates and gold grades at Gold Bar, which is also reporting faster recovery and lower strip ratio from the Pick deposit, setting the stage for improved production and margins in the second half of 2023 and beyond; and progress being made toward a formal construction decision at the Fenix project, where a sonic drilling program has been initiated along with progress made on permitting applications and hiring a project manager.

In addition, the company is reporting early retirement of $25 million, or 39%, of its outstanding debt during the second quarter with a safety track record of no lost-time incidents at its wholly owned operating mines. “The year started with operational challenges at both Gold Bar and San José,” said McEwen Mining chair and chief owner Rob McEwen in the press release. “San José appears to have turned the corner, and we are confident that the plan in place for Gold Bar will do the same. Fox Complex has delivered another solid quarter, and we expect even better results in the second half of the year. We thank our operating teams for their hard work. The story at Los Azules keeps getting better and better. With a strong financing, an updated Preliminary Economic Assessment (‘PEA’) showing robust economics, unparalleled partners in Rio Tinto (through Nuton) and Stellantis, and potentially game-changing copper leaching technology, we could see Los Azules provide a model for how the mine of the future should look.”

To view the full press release, visit https://ibn.fm/TxYTx

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, the company owns approximately 52% of McEwen Copper, which owns the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. McEwen Mining chair and chief owner Rob McEwen has a personal investment in the company of $220 million; his annual salary is $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tingo Group (NASDAQ: TIO), a profitable and fast-growing fintech and agrifintech company, has changed the date it plans to file form 10-Q for the second quarter, the period ending June 30, 2023. According to the announcement, the company has rescheduled the date for Aug. 21, 2023. The results will be shared during a second-quarter 2023 conference call and webcast scheduled for 8 a.m. ET; a press release will also be released with the information. Those interested in participating in the conference call, along with the Q&A segment, may dial toll-free 1-877-704-4453 or 1-201-389-0920 (internationally), then enter conference code 13739698. A replay of the call will be available through Sept. 21, 2023, by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and entering replay pin number 13739698. The postponement will allow independent counsel, which has been retained by Tingo’s independent directors, time to complete an independent review of the allegations made in the Hindenburg short-seller report. “Tingo’s independent directors believe it is in the best interest of both the company and its shareholders for the independent directors to receive the report of the independent review ahead of the company hosting its earnings call and issuing the company’s results for the second quarter ended June 30, 2023,” the announcement stated. ‘

To view the webcast, visit https://ibn.fm/m0S3g

To view the full press release, visit https://ibn.fm/38Ftg

About Tingo Group Inc.

Tingo Group is a global fintech and agrifintech group of companies with operations in Africa, southeast Asia and the Middle East. Tingo Group’s wholly owned subsidiary, Tingo Mobile, is a leading agri-fintech company operating in Africa, with a comprehensive portfolio of innovative products, including a “device-as-a-service” smartphone and a service-added platform. As part of its globalization strategy, Tingo Mobile has recently begun to expand internationally and entered into trade partnerships that are contracted to increase the number of subscribed farmers from 9.3 million in 2022 to more than 32 million, providing the farmers with access to services such as the Nwassa seed-to-sale marketplace platform, insurance, microfinance, and mobile phone and data top-up. Tingo Group’s other Tingo business verticals include TingoPay, a SuperApp in partnership with Visa that is currently in beta version and offers a wide range of B2C and B2B services including payment services, an e-wallet, foreign exchange and merchant services; Tingo Foods, a food-processing business that processes raw foods into finished products such as rice, groundnut oil, nut products, wheat, millet and maize; and Tingo DMCC, a commodity trading platform and agricultural commodities export business based out of the Dubai Multi Commodities Center. In addition to its Tingo business verticals, Tingo Group also holds and operates an insurance brokerage platform business in China, and Magpie Securities, a regulated finance services fintech business operating out of Hong Kong and Singapore. For more information, visit the company’s website at www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to TIO are available in the company’s newsroom at https://ibn.fm/TIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• GolfLync’s growth in members (15x in the past 4 months) is reminiscent of early-stage growth for companies like FaceBook (NASDAQ: META) and SnapChat (NYSE: SNAP)
• GolfLync’s membership conversion underscores its strength in the marketplace and ability to create innovative platform features users want
• GolfLync is growing because it understands how to create thriving online communities that connect its members together around their passion sport, GOLF

When it comes to new social media apps, the difference between hype and reality is seen in the numbers. GolfLync, a new and fast-growing social networking platform for golfers, has already garnered over 45,000 downloads, growing its member base more than 15x in just the past 4 months.

In comparison with other social media companies, GolfLync (available for download on the Apple App Store and the Google Play Store) has a top 25% conversion rate in its peer group (Social Networking) as…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to GolfLync are available in the company’s newsroom at https://ibn.fm/GOLF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

RYVYL (NASDAQ: RVYL), a company that leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions, has unveiled its coyni Mobile Point of Sale (“mPOS”) app. The new app enables iOS and Android devices to become POS terminals for merchants needing secure, efficient transactions. According to the announcement, the coynie mPoS app can be downloaded in beta mode from the Apple and Google stores. The new app enables merchants to accept contactless payments in person while ensuring seamless and secure transactions. The app, which is highly scalable to support a large number of terminals and users, creates unique QR codes that customers can scan and then use to pay, eliminating the need for merchants to use card readers. In addition, the app can process using customized business rules such as predefined percentages, dollar-based tips and consumer-specified amounts at the terminal level while also providing data insights and functionality.

“We are thrilled to announce the launch of coyni mPOS, which is a testament to the future success of the coyni platform and our dedication to its continued growth. This aligns with our overall strategy of creating value and brings us one step closer to our vision of spinning off coyni,” said RYVYL CEO and cofounder Fredi Nisan in the press release. “By integrating mPOS capabilities with the coyni platform, businesses and merchants can benefit from a comprehensive and user-friendly payment system coupled with the rounded foundation of the next beta release of the coyni business platform. Transactions can be executed with confidence using reliable and secure blockchain technology with each coyni digital token held in a wallet on the platform matched with one U.S. dollar held in a custodial account with a federally insured financial institution. The coyni platform can be utilized by both consumers and businesses for a wide range of payment purposes.”

To view the full press release, visit https://ibn.fm/Y84XW

About RYVYL

RYVYL was born from a passion for empowering a new way to conduct business-to-business, consumer-to-business and peer-to-peer payment transactions around the globe. By leveraging unique blockchain security and USD-pegged stablecoin technology with near real-time attestation, RYVYL is reinventing the future of financial transactions using its coyni(R) stablecoin platform as a transactional foundation. Since its founding as GreenBox POS in 2017, RYVYL has developed applications enabling an end-to-end suite of turnkey financial products with enhanced security and data privacy, world-class identity-theft protection and rapid speed to settlement. As a result, the platform can log immense volumes of immutable transactional records at the speed of the internet for first-tier partners, merchants and consumers around the globe. For more information about the company, please visit www.RYVYL.com.

NOTE TO INVESTORS: The latest news and updates relating to RVYL are available in the company’s newsroom at https://ibn.fm/RVYL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sharing Services (OTCQB: SHRG) is a company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies. Its subsidiary and leading producer and distributor of nootropic, functional beverage products, The Happy Co., recently unveiled a new limited-time seasonal flavor for its popular energy drink PerX and also launched a new probiotic dietary supplement product called Probio8. “Called Tropical Twist, the new PerX is a cool and refreshing energy drink designed to be ‘your neXt-level nootropic beverage.’ The Happy Co. initially announced its PerX brand in January 2023, and since then the energy drink has become one of the most popular choices in the company’s product offerings… In addition to its Tropical Twist announcement, SHRG’s The Happy Co. has launched a new probiotic dietary supplement product: Probio8. This gluten-free, sugar-free and vegan capsule offering contains eight different strains of beneficial probiotics, prebiotics and postbiotics, with each daily dose containing up to 23 billion healthy bacteria,” explains a recent article. “We’re committed to always expanding and improving what we do. Probio8 is a great example of how, even with our best products, we’re always looking for opportunities to innovate and to serve our customers better,” Sharing Services CEO John “JT” Thatch is quoted as saying.

To view the full article, visit https://ibn.fm/4wWGZ

About Sharing Services Global Corporation

Sharing Services is a publicly traded diversified company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies. The Sharing Services combined platform leverages the capabilities and expertise of various companies that market and sell products direct to the consumer. Additional information is contained in the company’s 10-Q and 10-K filings with the Securities and Exchange Commission. For more information, visit www.SHRGInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide biotherapeutics, nutraceuticals, cosmeceuticals, food and beverage, and other industries, today announced strongly accelerating orders for its UltraShear(TM)-processed Nano-CBD topical spray product. According to the update, the company has received seven initial market-seeding orders for UltraShear Nano-CBD from five new and two existing distributors in the three weeks following PBIO’s expansion into phase 2 of its commercial roll out.

“As previously explained, we strongly believe the marketplace has long been looking for a higher quality, effective, suitably nanoemulsified CBD product that can finally deliver fast and potent topical absorption of targeted benefits to users. The immediate response received from knowledgeable and experienced distributors, once they have been introduced to UltraShear Nano-CBD, has fully confirmed our expectations – they quickly ask for the opportunity to market our UltraShear-processed product,” said John B. Hollister, director of marketing and sales. “We are confident that the powerfully differentiated consumer experience will provide the all-important adoption driver complementing our sales and marketing efforts. Our team will be attending multiple key industry meetings to facilitate greater UltraShear exposure to key CBD industry players and to add additional distributors. Our goal is to expand to 25 distributors prior to year-end and 50 within 12 months. We believe each distributor will generate hundreds of thousands of dollars in annual revenue. Five new distributors and $300,000 in incremental revenue has been a gratifying start in the three-week period since launching our accelerated roll-out phase, but we believe it is just the ‘tip of the iceberg.’”

To view the full press release, visit https://ibn.fm/d05Qy

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and agrochemical, as well as food and beverage manufacturing. Its products utilize both constant and alternating pressure. The company’s patented enabling technology platform, Pressure Cycling Technology (“PCT”), utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are beginning to be widely used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterrorism applications. The company has recently expanded its market opportunities with the acquisition of the BaroFold(TM) patented technology platform, allowing it to enter the bio-pharma contract services and GMP manufacturing equipment sector. The company has also developed the scalable and high-efficiency pressure-based UltraShear Technology(TM) (UltraShear(TM)) platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. The company’s commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork